Cargando…

Rituximab during pregnancy in neuromyelitis optica: A case report

Detalles Bibliográficos
Autores principales:	Miranda-Acuña, Jahir, Rivas-Rodríguez, Erica, Levy, Michael, Ansari, Mustafa, Stone, Roslynn, Patel, Vivek, Amezcua, Lilyana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384016/ https://www.ncbi.nlm.nih.gov/pubmed/30800724 http://dx.doi.org/10.1212/NXI.0000000000000542

Ejemplares similares

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

Mortality in neuromyelitis optica is strongly associated with African ancestry
por: Mealy, Maureen A., et al.
Publicado: (2018)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Longitudinally extensive myelitis in MS mimicking neuromyelitis optica
por: Whittam, Daniel, et al.
Publicado: (2017)

Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease
por: Kaku, Michelle, et al.
Publicado: (2016)

Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy
por: Feyissa, Anteneh M., et al.
Publicado: (2015)

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
por: Gao, Fulin, et al.
Publicado: (2019)

Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
por: Etemadifar, Masoud, et al.
Publicado: (2017)

Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
por: Jade, Jui Dilip, et al.
Publicado: (2017)

Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
por: Nosadini, Margherita, et al.
Publicado: (2016)

Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders
por: Marcinnò, Andrea, et al.
Publicado: (2018)

Immunology of neuromyelitis optica during pregnancy
por: Davoudi, Vahid, et al.
Publicado: (2016)

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
por: Vaknin-Dembinsky, Adi, et al.
Publicado: (2016)

Secondary Hypogammaglobulinemia After Rituximab for Neuromyelitis Optica: A Case Report
por: Farhat, Lara, et al.
Publicado: (2018)

Efficacy of Low-Dose Rituximab on Neuromyelitis Optica-Associated Optic Neuritis
por: Zhao, Shuo, et al.
Publicado: (2021)

Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

Increased Circulating T Follicular Helper Cells Are Inhibited by Rituximab in Neuromyelitis Optica Spectrum Disorder
por: Zhao, Cong, et al.
Publicado: (2017)

Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
por: Yang, Yang, et al.
Publicado: (2021)

Rheumatoid arthritis with aquaporin-4 antibody-positive neuromyelitis optica receiving rituximab therapy
por: Reen Wang, Chrong, et al.
Publicado: (2021)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Evidence for classic complement activity in neuromyelitis optica
por: Jones, Melina V., et al.
Publicado: (2014)

Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
por: Levy, Michael
Publicado: (2018)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis
por: Wang, Hao, et al.
Publicado: (2021)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015)

Multisystem involvement in neuromyelitis optica
por: Langille, Megan M., et al.
Publicado: (2015)

A Case of Neuromyelitis Optica
por: DE, M. N., et al.
Publicado: (1946)

A Case of Neuromyelitis Optica
por: Shone, S.
Publicado: (1940)

Cannot write session to /tmp/vufind_sessions/sess_lmcnpk9ilkipaajfq2cq8l6del